“Oncoscope-AI has one big advantage. It’s weeding out the non-peer reviewed papers or manuscripts that are not published in good peer-reviewed journals. I know the quality will be high.”
“This tool helps me spend even more time than I already set aside with each individual patient.”
Oncoscope-AI, patient safety, and getting better answers faster with LLM
“This tool helps me spend even more time than I already set aside with each individual patient.”
Dr. Saro Sarkisian
Helping patients & staying up-to-date with Oncoscope-AI
More testimonials coming soon
Oncoscope-AI is being used in 47 U.S. States & Puerto Rico
Oncoscope-AI is being used in 19 EU member states
Subscribers from over 90 major hospitals, universities, and organizations including Top 20, C4QI, and NCI-designated cancer centers